Mölndal, Sweden

Karolina Nilsson


Average Co-Inventor Count = 9.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Karolina Nilsson: Innovator in Gastrointestinal Therapeutics

Introduction

Karolina Nilsson is a prominent inventor based in Mölndal, Sweden. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel compounds for gastrointestinal disorders. With a total of 2 patents to her name, her work is paving the way for innovative treatments in this critical area of healthcare.

Latest Patents

Karolina's latest patents include groundbreaking research on imidazole variants as modulators of the GABA receptor for the treatment of gastrointestinal disorders. This invention relates to novel compounds that exhibit a positive allosteric GABAB receptor modulator effect. The compounds are designed to inhibit transient lower esophageal sphincter relaxations, providing potential treatments for gastroesophageal reflux disease, functional gastrointestinal disorders, and irritable bowel syndrome (IBS). Another significant patent focuses on MGluR5 modulators, which are directed towards novel compounds, their preparation processes, therapeutic uses, and pharmaceutical compositions.

Career Highlights

Karolina is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. Her role involves extensive research and development aimed at creating effective therapeutic solutions for patients suffering from gastrointestinal issues. Her innovative approach and dedication to her work have established her as a key figure in her field.

Collaborations

Throughout her career, Karolina has collaborated with notable colleagues, including Andreas Christer Wallberg and Björn Holm. These partnerships have enhanced her research efforts and contributed to the successful development of her patented inventions.

Conclusion

Karolina Nilsson's contributions to the field of gastrointestinal therapeutics exemplify her commitment to innovation and patient care. Her work continues to inspire advancements in pharmaceutical research, making a significant impact on the treatment of gastrointestinal disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…